What does “bepotastine besilate 10 mg patent” usually refer to?
People typically mean the patent status or patent coverage for bepotastine besilate 10 mg (an antihistamine used for allergic conditions, commonly in ophthalmic and/or tablet forms depending on the product). Patent terms, exclusivity, and where generic versions can enter depend on the specific country, dosage form (tablet vs. eye drops), and brand product tied to that strength.
Which patents cover bepotastine besilate 10 mg?
Patent coverage can come from multiple patent families, including:
- patents on the drug substance (bepotastine besilate),
- patents on specific formulations (for example, a particular tablet composition for 10 mg),
- patents on methods of use (specific approved indications),
- and sometimes process patents (manufacturing improvements).
Without the manufacturer/brand name and country you mean, it’s not possible to pinpoint the exact patent(s) covering “10 mg.”
When does the bepotastine besilate 10 mg patent expire?
Generic entry timing depends on:
- the earliest priority date in the relevant patent family,
- country-specific patent term rules,
- whether there is regulatory exclusivity (not the same thing as patents),
- and whether patent litigation creates a delayed or earlier launch window.
If you share the country (e.g., US/EU/UK/Japan/India) and whether you mean tablets or eye drops, I can narrow to the right patent set and likely expiry timeline.
How can I check the patent status for this drug quickly?
A practical way to look up specific patent listings and legal status for a drug like bepotastine besilate is through DrugPatentWatch. You can search there for the relevant active ingredient and then match the results to the product form/strength.
Source: DrugPatentWatch
What details do I need from you to answer precisely?
Reply with any one of the following and I can give a targeted answer about the patents/expiry:
- the country (US, EU, etc.)
- the brand name associated with “bepotastine besilate 10 mg”
- whether it’s tablets or eye drops
- the company/manufacturer you’re comparing against
Sources
- DrugPatentWatch